MIRATI THERAPEUTICS INC's ticker is MRTX and the CUSIP is 60468T105. A total of 290 filers reported holding MIRATI THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is 0.39 and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2020 | $8,003,000 | -28.5% | 36,439 | -46.0% | 0.35% | -27.9% |
| Q3 2020 | $11,200,000 | +31.1% | 67,448 | -9.9% | 0.49% | +42.0% |
| Q2 2020 | $8,543,000 | +129.9% | 74,826 | +54.8% | 0.34% | +67.3% |
| Q1 2020 | $3,716,000 | -47.9% | 48,343 | -12.7% | 0.20% | -33.2% |
| Q4 2019 | $7,139,000 | +62.5% | 55,404 | -1.7% | 0.31% | +90.7% |
| Q3 2019 | $4,393,000 | +528.5% | 56,383 | +730.6% | 0.16% | +747.4% |
| Q2 2019 | $699,000 | -93.4% | 6,788 | -97.8% | 0.02% | -77.9% |
| Q3 2015 | $10,525,000 | – | 305,780 | – | 0.09% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Aviva Holdings Ltd. | 3,135,966 | $136,602,679 | 87.83% |
| EcoR1 Capital, LLC | 5,748,399 | $250,400,260 | 8.45% |
| Boxer Capital, LLC | 3,201,440 | $139,454,726 | 7.42% |
| RTW INVESTMENTS, LP | 6,768,514 | $294,836,470 | 6.22% |
| Paradigm Biocapital Advisors LP | 1,668,116 | $72,663,133 | 4.93% |
| Avoro Capital Advisors LLC | 6,666,666 | $290,399,971 | 4.53% |
| Octagon Capital Advisors LP | 655,051 | $28,534,022 | 4.38% |
| Artal Group S.A. | 2,024,226 | $88,175 | 3.78% |
| Ally Bridge Group (NY) LLC | 70,283 | $3,061,527 | 3.59% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 216,000 | $9,404,640 | 3.17% |